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Abstract
Aptamers are useful molecular recognition tools in research, diagnostics, and therapy. Despite promising results in other
fields, aptamer use has remained scarce in amyloid research, including Alzheimer’s disease (AD). AD is a progressive
neurodegenerative disease believed to be caused by neurotoxic amyloid b-protein (Ab) oligomers. Ab oligomers therefore
are an attractive target for development of diagnostic and therapeutic reagents. We used covalently-stabilized oligomers of
the 40-residue form of Ab (Ab40) for aptamer selection. Despite gradually increasing the stringency of selection conditions,
the selected aptamers did not recognize Ab40 oligomers but reacted with fibrils of Ab40, Ab42, and several other
amyloidogenic proteins. Aptamer reactivity with amyloid fibrils showed some degree of protein-sequence dependency.
Significant fibril binding also was found for the naı¨ve library and could not be eliminated by counter-selection using Ab40
fibrils, suggesting that aptamer binding to amyloid fibrils was RNA-sequence-independent. Aptamer binding depended on
fibrillogenesis and showed a lag phase. Interestingly, aptamers detected fibril formation with $15-fold higher sensitivity
than thioflavin T (ThT), revealing substantial b-sheet and fibril formation undetected by ThT. The data suggest that under
physiologic conditions, aptamers for oligomeric forms of amyloidogenic proteins cannot be selected due to high, non-
specific affinity of oligonucleotides for amyloid fibrils. Nevertheless, the high sensitivity, whereby aptamers detect b-sheet
formation, suggests that they can serve as superior amyloid recognition tools.
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Introduction
Alzheimer’s disease (AD) is a progressive neurodegenerative
disorder that initially presents as episodic memory lapses and
culminates in the decline of mental faculties, dementia, and death.
According to the Alzheimer’s Association, an estimated 5.3 million
Americans have AD in 2009 and this number will increase to 11–16
million by 2050 [1]. The annual cost of care for AD in the US is more
than $ 148 billion and will increase dramatically if effective prevention
and/or cure are not found. AD affliction typically occurs in the eighth
or ninth decade of life with incidence rising steeply after age 65.
Presymptomatic diagnosis of AD is difficult and clinical diagnosis relies
on patients’ history, cognitive assessment, and neuroimaging
providing an overall sensitivity of ,85% [2]. Definite diagnosis of
AD is achieved only by postmortem neuropathological examination.
Thus, an urgent need exists for development of diagnostics and early-
intervention tools for AD. Because the onset of AD occurs insidiously
many years before emergence of the initial symptoms [3], early
diagnosis is particularly important for effective therapeutic interven-
tion before progression to symptomatic disease [4].
Amyloid b-protein (Ab) is central to the pathogenesis of AD.
Presently, it is believed that soluble oligomeric, rather than
fibrillar, Ab assemblies act as the proximate neurotoxins that cause
synaptic dysfunction and neuron loss in AD [5,6]. Various forms
of soluble Ab assemblies, including low-molecular-weight (LMW)
oligomers, Ab-derived diffusible ligands, paranuclei, and proto-
fibrils have been described [7]. However, the interrelationships
amongst these Ab oligomers and their relevance to AD etiology
and pathogenesis remain unclear.
Biomarker discovery and specific molecular recognition tools
may unravel the interrelationships amongst Ab assemblies and
facilitate detection and characterization of these assemblies early
in the course of AD. Commonly, molecular recognition depends
on antibodies, which are indispensable diagnostic tools in research
and clinics. Many antibodies against Ab have been developed,
characterized, and used to enable highly specific detection of
different Ab assemblies [8–11]. Certain antibodies have been
reported to recognize conformational epitopes in Ab assemblies
and react with similar assemblies of other amyloidogenic proteins
[12–15], and some raised against oligomers recognize both
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oligomeric and fibrillar assemblies [15–17]. In the past two
decades, an alternative class of molecular recognition tools,
aptamers, has emerged offering important advantages relative to
antibodies, including rapid selection in vitro, high stability under
non-physiologic conditions, straightforward chemical manipula-
tion, low immunogenicity, and cost-effectiveness [18,19]. Partic-
ularly, single-stranded DNA (ssDNA) or RNA befit combinatorial
selection approaches because they fold into well-defined three-
dimensional structures and are easily amplified by polymerase
chain reaction (PCR).
Despite the emergence of aptamers as tools in modern
biotechnology and medicine [20], they have been underutilized
in the amyloid field. Most of the RNA or ssDNA aptamers for
amyloidogenic proteins have been selected against various forms of
prion proteins (PrP) [21–25]. Bunka et al. have generated aptamers
using monomeric and several forms of fibrillar b2-microglobulin
(b2m). The aptamers were found to bind fibrils of certain other
amyloidogenic proteins in addition to those of b2m [26]. In Ab
research, a single study described RNA aptamers selected against
immobilized monomeric Ab40 [27]. Despite selection against
monomeric Ab40, these aptamers showed binding to fibrillar
Ab40. These data raised several questions. Why did aptamers
selected against monomeric proteins recognize their polymeric
forms? Why did these aptamers not recognize the original targets,
i.e., the monomeric forms of those proteins? Could aptamers
against monomeric and/or oligomeric forms of amyloidogenic
proteins be obtained?
To address these questions, here, we attempted to generate
aptamers against covalently-stabilized oligomeric Ab40 generated
using photo-induced cross-linking of unmodified proteins (PICUP)
[28]. As our first target, we chose a cross-linked Ab40 trimer
because it is the predominant product when Ab40 is subjected to
PICUP. We describe the aptamers obtained and discuss the
implications and challenges of using in vitro selection of aptamers
for fibrillar and non-fibrillar assemblies of amyloid proteins.
Results
Systematic Evolution of Ligands by EXponential
Enrichment (SELEX) Targeting Covalently-Stabilized,
Trimeric Ab40
To target Ab40 trimers by in vitro selection, covalently-stabilized
Ab40 oligomers were generated using PICUP [29] and trimers
were purified using a newly developed protocol that allows high
protein recovery following SDS-PAGE separation (Rosensweig C.
J. et al., manuscript in preparation). We performed SELEX with
the purified, cross-linked Ab40 trimers using filter binding, and
increased the stringency of the selection gradually during the
process (see Materials and Methods). Progression of selection for
each RNA pool was monitored by filter-binding assay and
scintillation counting (Fig. 1). We observed 6.7% enrichment of
the initial RNA pool after 12 cycles (Fig. 1). We then cloned the
resulting aptamers and obtained 86 clones yielding 48 unique
sequences, named KM1–KM48. Motif analysis of 38 sequences
showed that all the aptamers had high (,70%) G content and
contained a conserved GGXGG motif.
In initial dot-blot screening experiments, we evaluated 33 unique
clones for their reactivity with trimeric or LMW Ab40 [30]. Dot
blotting does not affect protein conformation during the time-course
of these experiments [12,31,32]. Despite using stringent selection
conditions, none of the aptamers reacted with trimeric or LMW
Ab40 (up to 400 ng (,100 pmol) per spot). Low-molecular-weight
proteins, such as Ab, may not adsorb strongly to membranes and get
desorbed during wash steps. Therefore, we confirmed protein
adsorption and retention on blotting membranes by Ponceau S
staining after incubation with aptamers and subsequent washes.
Fig. 2A shows dot blotting and Ponceau S staining of trimeric and
LMW Ab40 for 3 representative aptamers—KM4, KM20, and
Figure 1. Progression of SELEX monitored by filter-binding
assay. Amount of bound radioactivity for each round of selection was
plotted as a percentage of total RNA count used for the corresponding
cycle.
doi:10.1371/journal.pone.0007694.g001
Figure 2. Characterization of aptamers selected against
trimeric Ab40. (A) LMW and trimeric Ab40 were spotted at 100 pmol
and membranes were probed with radioactively labeled RNA aptamers,
KM4, KM20, or KM33. Blots were stained with Ponceau S after probing
and washing to confirm protein retention. (B) Ab40 or Ab42 fibrils were
sonicated for 10 min, spotted onto nitrocellulose membranes, and
probed with aptamers KM33 and KM41.
doi:10.1371/journal.pone.0007694.g002
Anti-Ab40 Aptamers
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KM33. Because aptamers selected against monomeric Ab40 [27] or
monomeric b2m [26] were reported to bind Ab40 fibrils or various
forms of b2m fibrils, respectively, we assessed the reactivity of KM
aptamers against Ab40 and Ab42 fibrils. Similar to the previous
observations [26,27] and despite selection for covalently- stabilized
trimeric Ab40, all 33 unique aptamers bound Ab40 and Ab42
fibrils. KM33 and KM41 were selected out of the 33 clones for
further characterization based on their apparent preferential
binding to Ab40 fibrils observed in our initial screening. Both
KM33 and KM41 were found to react with as low as 50 ng
(,12 pmol) Ab40 or Ab42 fibrils (Fig. 2B).
KM Aptamers Bind Other Amyloid Fibrils
Under appropriate conditions, proteins with unrelated primary
structures form amyloid fibrils. The fibrils of these proteins share a
common cross-b structure and characteristic tinctorial and
morphologic properties [33]. Because certain antibodies have been
shown to react with fibrillar forms of various amyloid proteins
[13,14], it is thought that this common cross-b structure in amyloid
fibrils is the target. Thus, we assessed the selectivity of our aptamers
for Ab fibrils by examining whether they recognize fibrils of other
amyloidogenic proteins, including calcitonin, islet amyloid poly-
peptide (IAPP), insulin, lysozyme, and prion106–126. Each protein
was incubated under fibril-inducing conditions and fibrillar
morphology was confirmed by electron microscopy (EM) (Fig. 3)
prior to dot blotting. To compare aptamer reactivity quantitatively,
we analyzed the intensities of the fibril spots containing the highest
protein amount (500 ng) densitometrically. The reactivity of KM33
and KM41 with Ab40 was significantly (P,0.001) stronger than
with Ab42 (Fig. 4, Table 1). Both KM33 and KM41 reacted with
fibrils of other amyloid proteins. The aptamers reacted most
strongly with lysozyme and prion106–126, whereas the reaction with
calcitonin or insulin was relatively weak (Fig. 4, Table 1). The
reactivity with lysozyme and prion106–126 was significantly different
than with all the other protein fibrils (P,0.001). KM33 was more
reactive with all protein fibrils compared to KM41 but this
difference was statistically significant only for calcitonin (P,0.01).
Comparison of KM Aptamers with Previously Published
Anti-Ab40 Aptamers
To assess whether the reactivity of the KM aptamers with
amyloid fibrils of different proteins was unique, we examined anti-
Ab40 aptamers published previously [27]. Those aptamers were
selected against polymer-attached, N-terminally modified, Ab40
monomers which were coupled to the polymer column in 60%
1,1,1,3,3,3-hexafluoro-2-propanol (HFIP), a solvent that promotes
a-helix conformation and disaggregation of Ab [34]. One aptamer,
called b55, was shown by immunogold labeling and EM to bind
Ab40 fibrils [27]. We chose to examine four of the aptamers of Ylera
et al. (Table 1) that were reported to have the highest affinity for
polymer-attached Ab40 determined by affinity chromatography.
To test the selectivity of these aptamers, we used fibrillar
preparations of Ab and the 5 amyloidogenic proteins described
above. The reactivity of all four aptamers with the proteins tested
was similar and comparable to KM33 and KM41 (see Fig. 5 for an
example and Table 1 for the entire data set). Similar to KM33
(Fig. 4A) and KM41 (Fig. 4B), the reactivity of the aptamers of Ylera
et al. with Ab42 fibrils was somewhat lower than their reactivity with
Ab40 fibrils, suggesting moderate preference for Ab40.
Counter-Selection Against Ab40 Fibrils
Because in both our study and previous attempts to select
aptamers against monomeric forms of amyloid proteins [26,27]
the resultant aptamers were highly reactive towards amyloid
fibrils and not the monomeric or oligomeric targets, in
subsequent experiments, we attempted to counter-select against
fibrils. In these experiments, we performed SELEX using a
mixture of covalently-stabilized Ab40 oligomers as target because
this preparation was easier and faster to generate than gel-
purified Ab40 trimers. In addition, we suspected that if traces of
SDS were present in the previous experiment, they might have
accelerated Ab self-assembly and b-sheet formation [35]. Using
the oligomer mixture as a target alleviated the need for SDS-
PAGE separation and avoided the presence of SDS in the
preparation altogether. We performed 6 SELEX cycles with
counter-selections against Ab40 fibrils after the 4th and 5th cycles.
We then assessed the 3rd (before counter-selection) and the 6th
Figure 3. Morphologic characterization of fibrillar and unag-
gregated protein preparations. Electron micrographs of fibrillar
Ab40 (A), Ab42 (B), calcitonin (C), IAPP (D), insulin (E), lysozyme (F), and
prion106–126 (G). Insets show unaggregated preparations of the
corresponding proteins. Scale bars represent 200 nm.
doi:10.1371/journal.pone.0007694.g003
Anti-Ab40 Aptamers
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RNA pools for reactivity with the target—oligomeric Ab40, and
the unintended, cross-reactive species—Ab40 fibrils. We found
that both the 3rd and the 6th RNA pools reacted with Ab40 fibrils
but not with oligomeric Ab40 indicating that the counter-
selection against fibrils was inefficient (Fig. 6A). Although the
mixed oligomers were covalently stabilized, their dynamic nature
may cause relatively weak and/or short-lived RNA–peptide
interactions during SELEX reducing the power of SELEX cycles
to achieve selectivity. Moreover, the 6th RNA pool showed the
same pattern of reactivity with fibrils of Ab and the other
amyloidogenic proteins (Fig. 6B) as the KM aptamers (Fig. 4) and
the aptamers generated by Ylera et al. (Fig. 5, Table 1). Because
two counter-selections against Ab40 fibrils failed to remove fibril
reactivity of the 6th RNA pool, we attempted to restart from the
original RNA library and perform several ‘‘negative selections’’
against Ab40 fibrils in an effort to obtain an RNA pool devoid of
fibril-binding sequences. However, despite 5 consecutive rounds
of negative selection against excess (2 mg) Ab40 fibrils, the
percentage of RNA binding to fibrils, rather than decreasing,
increased from 0.1 to 1.7% (Fig. 7). Thus, similar to the counter-
selection cycles, the negative selection experiments did not reduce
RNA binding to Ab40 fibrils.
Assessment of Naı¨ve Libraries
In view of the persistent and apparently non-specific binding of
RNA aptamers to amyloid fibrils, we assessed whether RNA binding
was found in the naı¨ve library. In addition, because our sequencing and
motif analyses showed high G content in KM aptamers, we also tested
a biased library with reduced G ratio (A:C:G:T = 30:30:10:30%). We
found that both libraries reacted with fibrils of Ab40, Ab42, and the
other amyloid proteins (Fig. 8A, B) in a fashion similar to all the selected
aptamers tested (Figs. 4 and 5).
Figure 4. Reactivity of KM aptamers with different amyloid fibrils. Ab40, Ab42, calcitonin, IAPP, insulin, lysozyme, and prion106–126 were
spotted (1 mL) onto GSWP nitrocellulose membranes and probed with KM33 (A) or KM41 (B). Each blot is representative of four independent
experiments. Histograms show average densitometry values of the 500-ng protein spots. Values are expressed as mean6SEM.
doi:10.1371/journal.pone.0007694.g004
Table 1. Densitometry values of the reactivity of aptamers with fibrillar amyloid proteins.
KM33 KM41 b19{ b37{ b55{ b61{
Ab40 3862.5 28.861.4 22.364.5** 26.960.5* 2261.5** 22.661**
Ab42 18.460.6NNN 14.960.6NNN 10.561.5
*** 14.761NN 10.560.6
*** 9.660.4***NN
Calcitonin 0.960.1NNN 0.160.06
**
NNN 0.160.02
**
NN 0.860.2NNN 0.260.05
**
NN 0.360.2
*
NNN
IAPP 15.360.3NNN 10.260.7NNN 11.660.8 11.661.4NNN 12.362.4 10.261.1NN
Insulin 3.961NNN 0.960.1NNN 3.761.5N 4.561.6NNN 2.860.9NN 2.661.2NNN
Lysozyme 55.361.6NNN 37.961.6NN 5066.5NNN 45.663.1NNN 49.866.9NNN 39.363.9NNN
Prion106–126 54.563NNN 42.962.8NNN 48.264NNN 48.763.8NNN 47.263.6NNN 42.763.6NNN
*P#0.05, **P#0.01, and ***P#0.001, aptamer reactivity compared to KM33 reactivity with the same protein.
NP#0.05, NNP#0.01, and NNNP#0.001, reactivity of the same aptamer with Ab40 compared with the reactivity with other proteins.
{Aptamers reported by Ylera et al. [27].
doi:10.1371/journal.pone.0007694.t001
Anti-Ab40 Aptamers
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Aptamer Reactivity Depends on Protein Assembly State
Our experiments using the naı¨ve libraries suggested that
aptamer binding to fibrils reflected an inherent, sequence-
independent affinity of ribo-oligonucleotides for the fibrillar
structure of proteins. HFIP treatment has been reported to break
apart b-sheets, disrupt hydrophobic interactions, and promote a-
helical secondary structures [34]. Ab40 and Ab42 adopt
predominantly a-helical conformation when treated with 100%
HFIP [34]. This method has become standard in recent years
for preparation of aggregate-free Ab. Typically, the HFIP is
evaporated to dryness resulting in a peptide film that can then be
re-dissolved in the desired aqueous solution. Such ‘‘unaggregated’’
preparations of Ab40 and Ab42 have been obtained by dissolution
of dry, HFIP-treated peptide films in dimethyl sulfoxide followed
by dilution in phosphate-buffered saline [34]. These preparations
have been shown previously to be fibril-free [34]. To assess RNA-
sequence-independent affinity of aptamers for the protein
assembly state, we tested the reactivity of single aptamers and
the naı¨ve library with HFIP-treated proteins both directly, and
following ‘‘unaggregated’’ protein preparations.
Prior to blotting, we examined the morphology of ‘‘unaggre-
gated’’ proteins as shown in Fig. 3. An example of a dot blot
experiment is shown for KM33 in Fig. 9. KM33 did not react with
HFIP-treated Ab40, Ab42, calcitonin, insulin, or prion106–126.
However, it recognized HFIP-treated IAPP and lysozyme (Fig. 9A),
demonstrating that HFIP treatment of the latter two proteins did
not remove all the structural elements targeted by KM33.
Similarly, unaggregated preparations of Ab40, Ab42, calcitonin,
and insulin were not recognized by KM33 (Fig. 9B). Unaggregated
IAPP, lysozyme, and prion106–126 reacted with KM33 strongly
suggesting that they contained sufficient structural elements to be
detected by KM33 (Fig. 9B). Similar patterns of reactivity were
observed with KM41, all four of Ylera’s aptamers, and the naı¨ve
library (data not shown).
Evaluation of Aptamer Sensitivity
Aptamer reactivity with unaggregated and HFIP-treated IAPP,
and lysozyme suggested that even following HFIP treatment, these
proteins may contain sufficient b-sheet structure for aptamer
recognition. The behavior of prion106–126 suggested that HFIP
treatment disaggregated the peptide and disrupted b-sheet
structure, but those were rapidly formed upon dissolution in
buffer. Because b-sheet content increases with time during
fibrillogenesis, we tested the sensitivity of aptamers for formation
Figure 5. Reactivity of b19 aptamer with different amyloid
fibrils. Ab40, Ab42, calcitonin, IAPP, insulin, lysozyme, and prion106–126
were spotted (1 mL) onto GSWP nitrocellulose membranes and probed
with b19. The blot is representative of four independent experiments.
Histograms show average densitometry values of the 500-ng protein
spots. Values are expressed as mean6SEM.
doi:10.1371/journal.pone.0007694.g005
Figure 6. Reactivity of the 3rd and the 6th RNA pools with Ab40
and other amyloid fibrils. (A) Six SELEX cycles were performed using
cross-linked LMW Ab40 and the progression of SELEX was assessed after
two counter-selection cycles by testing the reactivity of the RNA pool
for Ab40 fibrils (400 and 800 ng) or cross-linked Ab40 (1,000 ng). Blots
were probed with RNA pools generated before (3rd cycle) and after (6th
cycle) counter-selection. (B) Fibrillar preparations of Ab40, Ab42,
calcitonin, IAPP, insulin, lysozyme, and prion106–126 were spotted at 5,
50, and 500 ng and the membranes were probed with the 6th RNA pool.
doi:10.1371/journal.pone.0007694.g006
Figure 7. Progression of negative-selection rounds using Ab40
fibrils. Amount of bound radioactivity for each round of negative
selection was plotted as a percentage of total RNA count used for the
corresponding cycle.
doi:10.1371/journal.pone.0007694.g007
Anti-Ab40 Aptamers
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of the b-sheet-rich fibrillar structure in two proteins. KM41, b19,
and the naı¨ve library were used to probe the fibrillogenensis of
Ab40 and insulin in this experiment. The two proteins were
chosen because their fibrillogenesis kinetics is relatively slow under
the conditions we used and allow reliable measurement. We
performed dot blotting simultaneously with thioflavin T (ThT)
fluorescence assay and examination by EM. The ThT assay has
been used commonly to study fibril formation in a number of
amyloidogenic proteins [36]. ThT micelles bind to b-sheet
structures resulting in an intensified fluorescence signal relative
to unbound ThT [37].
Initially, the aptamers or library did not bind to non-fibrillar
Ab40 or insulin (Fig. 10). Binding was observed after 90–120 min
and increased gradually suggesting that aptamer binding corre-
lated with the increase in b-sheet content. Both with Ab40 and
insulin, the aptamers recognized b-sheet conformation substan-
tially earlier than ThT fluorescence even though the amount of
protein in the dot-blot assay was 10-fold lower than in the ThT
assay (Fig. 10). Simultaneous EM examination indicated that
aptamer signals increased as soon as the first sparse fibrils formed
in both Ab40 (120 min; Fig. 10C) and insulin (60 min; Fig. 10F)
solutions. In contrast, ThT fluorescence started increasing only
when fibrillar species of Ab40 (270 min; Fig. 10C) or insulin
(120 min; Fig. 10F) were considerably more profuse. To compare
the aptamer and ThT sensitivities quantitatively, we calculated the
half-maximal time required to observe full reactivity (T50). When
assessing the time-course of Ab40 fibril formation, the T50 values
for KM41, b19, and the naı¨ve library (Fig. 10B; Table 2) were
significantly shorter (P,0.01) than that of the ThT fluorescence
assay (Fig. 10B; Table 2). Similarly, T50 values for KM41, b19,
and the naı¨ve library for insulin fibril formation were significantly
shorter (P,0.01) than that of the ThT fluorescence assay (Fig. 10E;
Table 2). Because 10-times more protein (,10 mg) was used for
each time point in the ThT assay compared to dot blotting (1 mg),
these results demonstrate that aptamers detect the increase in
b-sheet content with 15–17-fold higher sensitivity compared to
ThT fluoresence.
Discussion
Despite FDA approval of the first aptamer-based medication in
2005 [38], aptamers have been applied rarely to the amyloid field.
Several groups reported development of aptamers against prion
sequences [22–24,39], and aptamer-based detection assays for
prion proteins are now being developed [40]. Recently, aptamers
generated against various fibrillar forms of b2m were reported
[26]. An aptamer designated WL-2, generated against worm-like
b2m fibrils, was found to recognize three different fibrillar forms of
b2m and did not react with fibrils of apomyoglobin, Ab40, or
transthyretin (TTR). Remarkably, however, this aptamer bound
strongly to lysozyme fibrils [26]. Based on the data presented here,
this difference in reactivity likely reflects the higher non-specific
affinity of RNA oligonuclotides for lysozyme than for Ab40 (and
presumably also apomyoglobin and TTR, which we did not use).
Another aptamer selected against monomeric b2m, was shown to
bind long, straight b2m fibrils [26]. An RNA aptamer generated
against recombinant bovine PrP was shown to recognize bovine
PrP-b [41], a soluble, oligomeric, b-sheet-rich, conformational
variant of full-length PrP that forms amyloid fibrils [42].
Ylera et al. [27] selected aptamers against Ab40 coupled to a
Sepharose column through an engineered N-terminal cysteine. The
protein was coupled to the column under a-helix–promoting
conditions and the selected aptamers bound to the Sepharose-
coupled Ab40 with dissociation constants of 29–48 nM. However,
aptamer binding to Ab40 fibrils only was found and counter-elution
with soluble Ab40 did not lead to release of the aptamers from the
support column [27]. The authors suggested that the cross-reactivity
of the aptamers with Ab40 fibrils was due to potential aggregation of
Ab40 in the support column [27] despite the use of 60% HFIP
during the protein-coupling step. However, this explanation is
unlikely in light of data reported by Fezoui et al. [43] showing that in
Figure 8. Naı¨ve RNA libraries react with different amyloid fibrils in a pattern similar to individual aptamers. Fibrillar preparations of
Ab40, Ab42, calcitonin, IAPP, insulin, lysozyme, and prion106–126 at 5, 50, and 500 ng/mL were sonicated for 10 min and 1 mL was spotted onto GSWP
membranes. Membranes were probed with unbiased (A) or biased (B) library.
doi:10.1371/journal.pone.0007694.g008
Figure 9. Reactivity of KM33 with HFIP-treated and ‘‘unag-
gregated’’ proteins. HFIP-treated [34] (A) or unaggregated (B)
preparations of Ab40, Ab42, calcitonin, IAPP, insulin, lysozyme, and
prion106–126 were spotted at 500–2000 ng and probed with KM33.
doi:10.1371/journal.pone.0007694.g009
Anti-Ab40 Aptamers
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a 60% 2,2,2-trifluoroethanol (TFE) solution, Ab40 is predominantly
a-helical and non-aggregated. TFE is a weaker inducer of a-helical
conformation in Ab than HFIP [43]. Thus, efforts to generate
aptamers for amyloidogenic proteins have yielded sequences
recognizing fibrillar assemblies of these proteins but not their
monomeric form. Attempts to generate aptamers that would
recognize specifically oligomeric forms also have been unsuccessful
likely due to the dynamic nature of the oligomers preventing long-
lasting RNA–oligomer interactions and their capture, perpetuation,
and enrichment during SELEX cycles.
In an effort to generate aptamers selective for oligomeric Ab
and understand the reasons for the difficulty in achieving this goal,
we targeted covalently-stabilized, PICUP-generated trimers of
Ab40. Despite selection for 12 cycles with increasing stringency,
the selected aptamers did not react with trimeric or LMW Ab40
but bound Ab fibrils (Figs. 2, 4, 10), similar to the studies
mentioned above [26,27,41]. Thus, we were unsuccessful in
generating oligomer-specific aptamers. However, we gained
significant insight into the reasons for this failure. Fibril reactivity
of our aptamers was not unique to Ab as they also recognized the
fibrillar assemblies of five other amyloidogenic proteins (Fig. 4,
Table 1) with different affinities. The data obtained by us and
Figure 10. Comparison of ThT and aptamer detection sensitivity for b-sheet formation. Ab40 (A–C) or insulin (D–F) were incubated under
fibril-inducing conditions at a nominal concentration ,1 mg/mL. One-mL aliquots of Ab40 (A) or insulin (D) solution were spotted every 30 min for
480 or 300 min, respectively. The blots were probed with aptamers KM41 or b19, or the naı¨ve library. Spot intensities were quantified
densitometrically for 3 replicates, averaged, and plotted (B, E). Simultaneously, ThT fluorescence was recorded and compared with dot-blot
densitometry data. Aliquots were examined in parallel by EM (C, F). The scale bar denoting 200 nm applies to all EM panels.
doi:10.1371/journal.pone.0007694.g010
Table 2. Half-maximal T values (T506SE min) of aptamers and
ThT fluorescence assay for b-sheet detection.
Ab40 Insulin
KM41 26868** 10364**
b19 26467** 9764**
Naı¨ve library 315620** 9564**
ThT fluorescence 39569 17867
**P#0.01 compared to ThT fluorescence assay.
doi:10.1371/journal.pone.0007694.t002
Anti-Ab40 Aptamers
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others suggest that aptamers generated against amyloidogenic
proteins recognize a structural motif that is common to the fibrillar
form of these proteins. This motif, likely is the backbone of the
proteins in a cross-b structure. The reactivity clearly is RNA
sequence-independent but depends on the protein assembly state
and to some extent on the protein sequence.
The inherent and persistent tendency of amyloid fibrils to bind
RNA may explain the observation that senile plaques and
neurofibrillary tangles, the two pathological hallmarks of AD
brains, contain RNA [44–46]. It has been suggested that amyloid
fibrils and oligonucleotides may act as polyelectrolytes interacting
by electrostatic forces [47]. Such b-sheet-mediated protein–nucleic-
acid interactions may have been essential for scaffolding, stability,
compartmentalization, protection, and degradation resistance
under the harsh conditions of the primordial, prebiotic world [48].
Commensurate with the idea that electrostatic interactions are
an important determinant of aptamer–fibril interaction, the
preferential binding of the aptamers (and libraries) used here for
lysozyme and prion106–126, correlate with the high pI values of
these proteins, 9.82 and 10.00, respectively. However, isoelectric
point (or net positive charge) alone do not account for the pattern
of reactivity we observed because linear regression analysis of
aptamer affinity versus pI yields weak correlation (r2 = 0.42). The
actual affinity likely depends on a number of factors, including the
number of aptaopes per unit mass, exposure and availability of
aptatopes under particular experimental conditions, and percent
b-sheet content, in addition to the fibril surface charge.
Our data demonstrate that incubation in HFIP, a common
treatment which presumably provides aggregate-free starting
material for biophysical and biological studies of amyloidogenic
proteins, is useful for Ab40, Ab42, calcitonin, and insulin but not
entirely efficient for disaggregating IAPP and lysozyme, and its
utility is questionable for prion106–126 (Fig. 9). Our data for Ab are
in agreement with those of Stine et al. who have reported that
unaggregated and HFIP-treated preparations of Ab40/Ab42 were
aggregate-free and contained ,1% b-sheet measured by circular
dichroism spectroscopy [34].
Owing to their inherent non-specific tendency to bind amyloid
fibrils, oligonucleotides may be suitable as highly sensitive amyloid
detectors. Our results indicate that aptamers can be used to detect
early b-sheet formation more sensitively than the common ThT
assay (Fig. 10) and that despite its popularity, the ThT assay does
not detect b-sheet content formed in protein samples during early
fibrillogenesis. Thus, these aptamers may facilitate highly efficient
detection of advent of b-sheet formation in histopathological and
in biophysical studies in vitro. Achieving high-sensitivity, aptamer-
based detection of b-sheet formation depends on further
development and streamlining of fast, refined, and easy quanti-
tative assays. These assays potentially will complement methods
that assess b-sheet-formation kinetics.
Aptamers have been shown to discriminate targets on the basis
of subtle structural differences [49,50]. Exploitation of such a
selective power is yet to be achieved for aptamers in the amyloid
field. If aptamers are to be obtained for diagnostic and therapeutic
applications in amyloid diseases, future experiments aimed at
generating avid and specific aptamers for pre-fibrillar assemblies,
including monomers and oligomers, will have to address the
inherent affinity of oligonucleotides for fibrillar structures.
Materials and Methods
Protein Preparation
Ab40 was synthesized and characterized as reported previously
[51]. For initial experiments, trimeric Ab40 was used as the target
for in vitro selection. Covalently-stabilized Ab40 oligomers were
generated using PICUP [28] and purified as described elsewhere
(Rosensweig C. J. et al., manuscript in preparation). Briefly,
following SDS-PAGE fractionation using 10–20% gradient
Tricine gels (Invitrogen, Carlsbad, CA) and SimplyBlue Coomas-
sie staining (Invitrogen), Ab40 dimer (for counter-selection) and
trimer (for selection) bands were excised off the gels. The gel bands
were diced into small pieces, washed thrice in deionized water
(18.2V, Millipore, Bedford, MA), subjected to 3 freeze–thaw cycles
to make them brittle, and finally crushed by a mini-pestle. The
crushed acrylamide was rotated end-over-end in 0.1% NH4OH
for 1 h at 23uC to allow protein extraction. After centrifugation
(750 g, 10 min, 23uC), the supernates were treated with SDS-
OUT (Pierce, Rockford, IL) to remove SDS. Then, samples were
dialyzed using 2,000-Da molecular weight cutoff Spectra/Por
dialysis membranes (Spectrum Laboratories, Rancho Dominguez,
CA) first against 10 M urea (4uC for 12 h), followed by ten
changes of deionized water over 48 h to remove remaining SDS
and Coomassie stain. The resultant solution was collected,
lyophilized and kept at 280uC until use for aptamer selection.
In experiments using a mixture of PICUP-stabilized Ab40
oligomers as the target for SELEX, cross-linked oligomers were
subjected to buffer exchange and cross-linking reagents were
removed using D-Salt Excellulose Desalting Columns (Thermo
Fisher Scientific, Rockford, IL) in 10 mM ammonium acetate,
pH 8.3. The cross-linked mixture of Ab40 monomer and
oligomers was lyophilized and treated with HFIP as described
previously [52]. The HFIP then was evaporated and the protein
films stored at 220uC. The integrity of the PICUP-generated
oligomers was assessed by analyzing an aliquot using SDS-PAGE.
Because SDS may induce artificial Ab oligomerization [35], in
separate experiments, cross-linked Ab40 oligomer mixtures were
analyzed by both SDS-PAGE and size-exclusion chromatography,
which confirmed the presence of bona fide dimers, trimers, and
tetramers (data not shown). Protein concentrations were deter-
mined using amino acid analysis.
In Vitro Selection Using Ab40 Trimers
A synthetic ssDNA library (Integrated DNA Technologies,
Coralville, IA) for SELEX [53,54], included 49 randomized
nucleotides (A:T:G:C = 25:25:25:25%) flanked by constant regions
that incorporated cloning sites (BamHI, EcoRI) and a T7 promoter,
as described previously [55] (Fig. 1). Using the double-stranded,
PCR-amplified DNA template, RiboMAX Large-Scale RNA
Production System-T7 (Promega, Madison, WI) was used to
transcribe 32P-labeled RNA by internally incorporating a32P-
cytidine triphosphate (GE Healthcare, Piscataway, NJ or Perkin
Elmer, Waltham, MA). After phenol-chloroform extraction and
desalting using Illustra MicroSpin G-50 columns (GE Healthcare),
RNA integrity was confirmed by electrophoresis using 6% Tris-
borate-EDTA-urea acrylamide gels (Invitrogen) and autoradiog-
raphy for 30–60 min. RNA quantification was performed by
scintillation counting using a Triathler bench-top scintillation
counter (Hidex Oy, Turku, Finland).
Aptamers were selected in 12 rounds of SELEX using filter-
binding for partitioning and assaying the bound RNA pool [55].
Before each round of SELEX, RNA was denatured at 90uC for
10 min and renatured at 23uC for 10 min. The RNA pool was
pre-cleared using 0.45-mm pore size, HAWP02500 nitrocellulose
filters (Millipore) to remove non-specific, filter-binding sequences
before each selection round. Because Ab40 trimers were purified
off Coomassie-stained gels, RNA pools also were pre-cleared using
Coomassie-stained HAWP filters after the 8th and 12th SELEX
rounds to remove sequences that would potentially bind the
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Coomassie stain. Counter-selection against cross-linked dimeric
Ab40 was performed before the 5th and 10th SELEX rounds.
Renatured RNA pool (100 pmol, ,661013 different sequences)
and trimeric Ab40 (400 pmol) were incubated in binding buffer
(140 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 2 mM
KH2PO4, pH 7.4) at 23uC for 60 min before separating the
protein-bound RNA from the unbound fraction. Over the course
of SELEX, the protein:RNA ratio was decreased gradually from
4:1 to 1:1 to 1:2 in the first 7 rounds, next 3 rounds, and final 2
rounds, respectively. tRNA (10 mg/mL) was added to the selection
reaction in the last 3 rounds to compete off non-specific RNA
binding. After washing the filter 5 times with wash buffer (120 mM
NaCl, 8 mM Na2HPO4, 1.9 mM NaH2PO4, 4.5 mM KCl,
0.12 mM MgSO4, 40 mM N-(2-hydroxyethyl)piperazine-N’-(2-
ethanesulfonic acid), pH 7.4), the amount of filter-bound RNA
was measured by scintillation counting of the filter and eluted in
7M urea, 100 mM sodium citrate, 3 mM EDTA, pH 7.0, as
described previously [55]. Subsequently, the RNA pool was
reverse-transcribed into cDNA by the ImProm-II Reverse
Transcription System (Promega) and amplified by PCR followed
by in vitro transcription for the next selection rounds. After the last
cycle, individual aptamer clones were obtained by ligation of the
PCR products into pGEM3Z vectors after digestion with EcoRI
and BamHI (USB, Cleveland, OH).
In Vitro Selection Using Mixed PICUP-Stabilized Ab40
Oligomers
Ab40 oligomers were reconstituted in Tris-buffered saline (TBS,
10 mM Tris-HCl, 150 mM NaCl, 5 mM MgCl2, 1 mM EDTA,
pH 7.5) at 1–3 mM. Because the aptamers selected for cross-linked
Ab40 trimers were found to bind fibrils (see Results), we were
concerned that fibril formation by cross-linked oligomers might
have occurred during incubation of oligomers with RNA. To
assess whether that was the case, 3 mM of the mixture of cross-
linked oligomers were incubated under identical conditions to the
ones used for selection (in the absence of RNA) and monitored by
turbidometry at A400 nm. Following a ,45–60 min lag phase, the
turbidity increased gradually and then reached a plateau,
indicating particle growth. Based on these data, to ensure that
no aggregation took place during incubation of RNA with the
cross-linked oligomers, the incubation duration was shortened to
15 min. Three hundred to 1,000 pmol cross-linked Ab40
oligomers were incubated with the RNA pool. The amount of
RNA incubated with the protein target was reduced gradually
from ,100 nmol (,661016 different sequences) in the first cycle
to 4 nmol in the 6th cycle. For filter binding in this case we used
0.22-mm pore-size nitrocellulose GSWP02500 membranes (Milli-
pore) to minimize protein loss observed in the previous experiment
using 0.45-mm pore-size membranes. Pre-clearing of the RNA
pool against the GSWP filters was performed before each cycle
starting at round 3. Two counter-selection rounds against 10 or
20 nmol Ab40 fibrils were performed after the 4th and 5th SELEX
cycles, respectively. The number of washes with TBS (0.5 mL
each) was increased from 2 in the first 4 cycles to 6 in round 5, and
to 10 in the 6th cycle to increase selection stringency. tRNA
(2.5 mg/mL) was incubated with the mixture of RNA and the
target in the 6th cycle for increased competition. After the 6th cycle,
the SELEX progression and selectivity were monitored by
assessing the reactivity of the RNA pool with Ab40 oligomers
and fibrils.
Anti-Ab40 Aptamers Previously Published by Ylera et al.
RNA sequences of aptamers designated b19, b37, b55, and b61
have been published previously ([27] and Dissertation by Ylera
Dahmen, Francisco entitled ‘‘Selektion hochaffiner RNA-moleku¨le
gegen das Alzheimer b-amyloid’’, Freie Universita¨t Berlin (1999)
available at http://deposit.ddb.de/cgi-bin/dokserv?idn = 961044268).
Complementary DNA sequences for these aptamers and primers A
(59-TAATACGACTCACTATAGGGAATTCGA-GCTCGGTAC-
C-39) and B (59-CCAAGCTTGCATGCCTGCAG-39) were obtained
from Integrated DNA Technologies. PCR was used to amplify the
DNA sequences and to incorporate a T7 promoter using primer A.
RNA aptamers were produced by in vitro transcription and 32P-labeled
as described above.
Aptamer Sequencing and Analysis of Secondary
Structure
Cloned DNA was sequenced using an Applied Biosystems 3730
DNA Analyzer (Applied Biosystems, Foster city, CA) at the UCLA
GenoSeq Genotyping and Sequencing Core Facility. Alignment
search, classification, and local supermotif analysis were performed
using sequences of 33 unique aptamers by Multiple Expectation
maximization for Motif Elucidation [56] and Clustal W, version
2.0 [57]. To identify common secondary structural motifs, RNA
sequences were folded using the energy minimization algorithm of
Mfold [58].
Preparation of Non-Fibrillar Protein Assemblies
LMW Ab40 was prepared as described previously [30].
‘‘Unaggregated’’ preparations of human Ab40, Ab42, calcitonin
(American Peptide Company), IAPP (AnaSpec Inc., San Jose,
CA), insulin (Sigma, St Louis, MO), lysozyme (Sigma), and
prion106–126 (American Peptide Company, Sunnyvale, CA) were
prepared as described previously [34]. Alternatively, HFIP-treated
proteins were prepared as described previously [52]. Unaggre-
gated and HFIP-treated proteins were used immediately for dot-
blot analysis. Aliquots of unaggregated preparations were taken for
EM analysis.
Preparation of Fibrillar Protein Assemblies
All solvents were prepared under RNase-free conditions,
contained 0.02% sodium azide to prevent bacterial growth, and
were filtered through 0.02-mm Anotop filters (Whatman Interna-
tional Ltd. Maidstone, England) to remove particulate material.
Ab fibrils were prepared by reconstituting lyophilized peptides at
2 mg/mL in 6 mM NaOH in deionized water. Peptide solutions
were sonicated for 2 min, then diluted with an equal volume of
20 mM phosphate, pH 7.4, and centrifuged at 16,000 g to
precipitate large aggregates and obtain a homogeneous starting
solution. Supernates were incubated at 37uC with rotary agitation
(200 rpm) for 1 week. Calcitonin [59], IAPP [60], insulin [61],
lysozyme [62], and prion106–126 [63] fibrils were prepared under
appropriate conditions for each protein as described previously.
Once fibrils formed, the preparations were washed 5 times in
10 mM phosphate buffer, pH 7.5, centrifuged after each wash to
remove non-fibrillar material, quantified by amino acid analysis,
and the fibrils finally suspended in buffer and stored at 220uC.
Morphological Characterization of Protein Assemblies
The morphology of all fibrillar and unaggregated protein
preparations was assessed by EM with negative staining. Briefly,
8–10 mL of protein preparation were applied to glow-discharged,
carbon-coated Formvar grids (Electron Microscopy Sciences,
Washington, PA) for 10–20 min. The solution was gently wicked
off using Whatman grade-1 qualitative filter paper. Grids were
treated with 10 mL of 0.5% (v/v) glutaraldehyde for 1 min and
wicked dry. After rinsing with two 10-mL aliquots of water, samples
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were stained with 10 mL of 2% uranyl acetate (w/v, Pfaltz &
Bauer, Inc., Waterbury, CT) for 2 min. The stain solution was
wicked off and grids air-dried. Grids were examined using a Core
JEOL Electron Microscope at 29,0006 magnification at the
UCLA Brain Research Institute Microscopy Core Facilities.
Dot Blotting, Densitometry, and Statistics
All fibrillar preparations were sonicated for 10 min prior to dot
blotting to produce fragmented short fibrils allowing uniform
suspension, and diluted in a range of concentrations (5–500 ng/mL)
before spotting. After mixing, 1-mL aliquots were spotted onto 0.2-
mm pore-size, custom-ordered 966 cm, GSWP nitrocellulose
membranes (Millipore) and air-dried. Non-fibrillar protein prepa-
rations were spotted in 1–2-mL aliquots to obtain the desired protein
amount (500–2,000 ng) immediately after protein solubilization.
Blots were rinsed and incubated in TBS. Each aptamer was
denatured by pre-heating at 90uC (10 min), renatured by cooling to
23uC (10 min), and added to the buffer (56105 cpm/mL, 23uC).
After 30 min, blots of fibrillar preparations were washed (10-min
cycles, typically 7–10 times) in TBS containing 0.05% (v/v) Tween-
20 (Sigma) until only background radioactivity was detectable in the
wash buffer. TBS containing Tween-20 was found to desorb non-
fibrillar preparations off the membrane following incubation with
aptamers. Therefore, blots of unaggregated or HFIP-treated protein
preparations were washed multiple times in TBS excluding Tween-
20 until no radioactivity was found in the rinse. Blots were dried,
wrapped in plastic wraps, exposed to X-ray films for 72 h, and
developed. Subsequently, blots were stained with Ponceau S
(3-hydroxy-4-(2-sulfo-4-[4-sulfophenylazo]phenylazo)-2,7-naphtha-
lenedisulfonic acid; Amresco, Solon, OH) to confirm protein
retention.
The fibril spots containing the highest protein amount (500 ng)
were analyzed by densitometry using Gilles Carpentier’s Dot-Blot-Analyzer
macro (written by Gilles Carpentier, 2008. The macro is available
at http://rsb.info.nih.gov/ij/macros/toolsets/Dot%20Blot%20Analyzer.
txt and more information can be found at http://image.bio.
methods.free.fr/dotblot.html) written for ImageJ [64]. Data are
expressed as (mean6SEM). One-way analysis of variance
(ANOVA) was performed and Tukey’s test assessed differences
which were considered significant if P#0.05.
Comparison of Thioflavin T Fluorescence Assay and
Aptamer Detection Sensitivity
To assess progression of fibril formation, thioflavin T (ThT)
assay, dot blotting, and EM were used to monitor solutions of
Ab40 or insulin contemporaneously. The reactions were per-
formed in triplicates. ThT and dot-blot assays were used to
monitor all 3 replicates whereas EM was used to monitor one out
of the three. Three mM stock ThT solution prepared in deionized
water was stored at 4uC in the dark to prevent photo bleaching.
For insulin (nominally 1 mg/mL; prepared as above), 10-mL
aliquots of the solution were added to 300 mL of 30 mM ThT in
50 mM glycine/NaOH, pH 8.0. For Ab40 ThT assay, 10-mL
aliquots of Ab40 (nominally 1 mg/mL; prepared as above) were
added to 300 mL of 30 mM ThT in 10 mM phosphate buffer,
pH 7.5, because these conditions gave higher sensitivity than
glycine/NaOH buffer. The fluorescence emission spectra were
recorded following a 5-min incubation using an F-4500 Fluores-
cence Spectrophotometer (Hitachi High-Technologies Corpora-
tion, Japan) with lex = 450 nm, 5-nm slit and lem = 482 nm, 10-
nm slit. Disposable, Plastibrand, semi-micro UV cuvettes (Fisher
Scientific, Pittsburgh, PA) with a 1-cm excitation light path were
used for fluorescence spectrophotometry. EM grids were prepared
as described above. For dot blots, 1 mL (,1 mg protein) was
spotted on GSWP membranes at each time point and subse-
quently probed with aptamers. Blots were incubated with
aptamers as described above and developed by autoradiography.
The films were scanned and the dot-blotting densitometry and
ThT data were fitted using the Boltzmann sigmoidal function:
Y~Fminz
Fmax{Fminð Þ
1
T50{X
Slopeð Þ
, where Fmax and Fmin denote the
fluorescence/densitometry measures, respectively, and T50 denotes
the time when the fluorescence/densitometry values are half-
maximal between Fmin and Fmax. T50 values were calculated using
Prism 5.0b (GraphPad Software, Inc., La Jolla, CA), expressed as
average
6SE, and statistical significance was calculated by ANOVA
followed by Dunnett’s Multiple Comparison test assessing pair-
wise differences which were considered significant when P#0.05.
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